Jump to content

Clonidine: Difference between revisions

From Pharmacopedia
[unchecked revision][unchecked revision]
Recategorize: Stimulants & Wake-Promoting Agents -> Stimulants
Recategorize: Stimulants -> Psychostimulants
Line 32: Line 32:




[[Category:Stimulants]]
[[Category:Psychostimulants]]
[[Category:Psychostimulants]]
[[Category:Psychostimulants]]
[[Category:Alpha-2 Agonists (for ADHD)]]
[[Category:Alpha-2 Agonists (for ADHD)]]
[[Category:Alpha-2 agonists for withdrawal]]
[[Category:Alpha-2 agonists for withdrawal]]
[[Category:Addiction Medicine]]
[[Category:Addiction Medicine]]

Revision as of 10:50, 17 May 2026

Alpha-2 agonist, ADHD medicine
Clonidine
Kapvay

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Interactions

Pharmacogenomic + mechanism interactions2 edges
Pharmacokinetic mechanismSubstrate / metabolism relationships from primary literature
Transporter:SLC22A2 inhibitor Primary 70 / 100
FDA Drug Interactions Table: transporter inhibitor (SLC22A2).
Inferred from pharmacokinetic dataMaterialised by the inference engine; provenance shown per row
Metformin pk raises via SLC22A2 Inferred 49 / 100
Clonidine inhibits SLC22A2 (inhibitor, intensity 70); Metformin is a substrate of SLC22A2 (intensity 70). Derived: Metformin exposure raised.
Inferred via Enzyme:SLC22A2 (exposure raised)

Patient experience

No patient-experience reports yet.

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Classes
Alpha-2 agonist, ADHD medicine
Common uses
Pharmacy
Pharmacology
Purported mechanism
Alpha-2 adrenergic receptor agonist